[144] CME GROUP INC. SEC Filing

Rhea-AI Filing Summary

CME Group Inc. filed a Form 144 notifying of a proposed sale of 376 shares of common stock through Morgan Stanley Smith Barney LLC, for an aggregate market value of $97,368.96. The shares were acquired as restricted stock from the issuer on 09/15/2025 and the proposed sale date is 09/16/2025 on NASDAQ. The filing shows 360,377,042 shares outstanding, and the filer states they are unaware of any undisclosed material adverse information. No sales by the filer in the past three months are reported.

Insights

Financial Analyst

TL;DR The proposed transaction is immaterial to company capitalization and likely routine insider liquidity.

The filing discloses a small block of 376 newly acquired restricted shares being offered for sale immediately after vesting, with an aggregate value of $97,368.96 versus 360,377,042 shares outstanding. From a market-impact perspective, this quantity represents a de minimis fraction of outstanding shares and is unlikely to affect market price or signal major insider sentiment. The representation that no undisclosed material adverse information exists is standard for Form 144 submissions.

Corporate Governance Expert

TL;DR Disclosure aligns with Rule 144 requirements; timing suggests compliance rather than strategic disposition.

The document reports the required broker, acquisition date, and payment details for restricted stock sales and includes the signature representation regarding material information and any 10b5-1 plan adoption. The immediacy of sale (one day after acquisition) is noted but, given the small size relative to total outstanding shares, this appears to be routine insider liquidity and compliant with disclosure rules. There is no indication of material governance issues in the filing itself.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	376	97368.96	360377042	09/16/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2025	Restricted Stock	ISSUER			376	09/15/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CME Group's Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 376 common shares via Morgan Stanley Smith Barney LLC with an aggregate market value of $97,368.96 and an approximate sale date of 09/16/2025.

When were the shares acquired that are proposed to be sold in CME's Form 144?

The shares were acquired as restricted stock from the issuer on 09/15/2025 and payment (if applicable) is recorded as 09/15/2025.

How large is the proposed sale relative to CME Group's outstanding shares?

The proposed sale of 376 shares compares to 360,377,042 shares outstanding, making it an immaterial percentage of the outstanding share count.

Does the Form 144 indicate any undisclosed material information about CME Group?

By signing the notice, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.

Were there any other sales by the filer in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.